Status epilepticus (SE) is a neurologic emergency with a high mortality rate. Fast progression of SE and lack of response to traditional antiseizure mediations in many cases has challenged clinicians to use new agents. Understanding the mechanism of action, dosing strategies, adverse effects, monitoring parameters, and evidence regarding efficacy of these agents in SE, as well as knowing the most appropriate patient population to target is crucial.
- Provider:Society of Critical Care Medicine
- Activity Link: https://congress2024.sccm.org/aaStatic.asp?SFP=VFJVUUtHWFdAMTU3NjlAQ29uZ3Jlc3MgRGlnaXRhbA
- Start Date: 2024-01-21 06:00:00
- End Date: 2024-01-21 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABA - 1.0 Point; Credit Type(s): Lifelong Learning (ABA)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Critical Care Medicine, Pediatric Critical Care Medicine, Surgical Critical Care
Subscribe
Login
0 Comments
Oldest